Short answer
Tumor testing looks for variants inside the paraganglioma itself. Germline testing looks for inherited variants in blood, saliva, or another normal tissue. In a PPGL case, a tumor-only result can be useful, but it does not automatically prove inherited risk. Germline testing is what answers the family question.
That is why these two tests are often paired in real life. One helps describe the tumor, the other helps define whether relatives may also be at risk.
How to separate the test types
| Test type | What it can answer | What it may not answer |
|---|---|---|
| Tumor-only testing | What variants are present in the tumor? | Whether the variant is inherited. |
| Germline testing | Is there an inherited PPGL syndrome? | Every tumor-specific driver. |
| Paired tumor-normal testing | Which changes are somatic versus inherited? | Some mosaicism and technical limits may remain. |
When tumor testing helps
Tumor testing helps when the question is biology: what changes are in the lesion, and do they suggest a pathway, treatment angle, or syndrome clue? Endotext and broader PPGL reviews note that tumor profiling can show somatic changes that germline testing would miss. That matters because some PPGLs are driven by tumor-only changes that never appear in blood.
But tumor testing alone is not enough to call something inherited. A finding can be real and still be limited to the tumor.
When germline testing matters
Germline testing matters when the goal is inherited risk. GeneReviews says all individuals with paraganglioma or pheochromocytoma should be referred for molecular genetic testing, and NCI says genetic counseling is part of care for these patients. That is the step that can change surveillance and targeted testing for relatives.
Germline testing is also the path that helps separate syndromes such as SDHx-related PPGL, VHL, RET/MEN2, NF1, TMEM127, MAX, and EPAS1 when the tumor pattern is not obvious from pathology alone.
When paired testing is best
Paired tumor-normal testing is best when the first tumor result raises the question “somatic or inherited?” and the answer matters for counseling. It can show whether a variant appears in the tumor only or also in normal tissue. That is often the cleanest way to avoid overcalling inherited risk from a tumor report.
It is especially useful when the patient has an early-onset tumor, multifocal disease, a family history, or a tumor pattern that still leaves more than one syndrome on the table.
Questions to ask
- Was the sample tumor tissue, blood, saliva, or paired tumor-normal?
- Did the report call the variant somatic, germline, suspected germline, or uncertain?
- Does the finding involve SDHx, VHL, RET, NF1, MAX, TMEM127, EPAS1, or another PPGL gene?
- Would relatives need targeted testing, or is the result tumor-only?
- Is a genetics referral recommended before changing surveillance?
- What metanephrines, imaging, or pathology details still need to be reviewed?
When follow-up matters more
Follow-up matters more when a paraganglioma or pheochromocytoma result could change who in the family should be tested, when tumor-only and germline questions are still mixed together, or when a specialist plan should decide surveillance timing rather than a single lab result. Genetics counseling helps keep the finding tied to the actual family question.
FAQ
What is the difference between tumor testing and germline testing?
Tumor testing looks for variants in the tumor itself, while germline testing looks for inherited variants in blood, saliva, or another normal tissue. A tumor result may help explain biology or treatment, but it does not by itself prove inherited family risk.
When is tumor testing useful?
Tumor testing is useful when the question is which variants are present in the lesion and whether they might explain the tumor’s behavior. It can also help with paired tumor-normal interpretation and may point toward a hereditary syndrome that should be confirmed in normal tissue.
When is germline testing useful?
Germline testing is useful when the goal is to find inherited risk for the patient and relatives. NCI notes that genetic counseling is part of care for people with pheochromocytoma or paraganglioma, and GeneReviews recommends molecular genetic testing for these tumors.
Does a tumor-only result count as inherited?
No. A tumor-only result does not prove inheritance. It may be somatic, meaning acquired in the tumor, and paired tumor-normal or blood testing is usually needed before family risk is assigned.
When is paired tumor-normal testing best?
Paired tumor-normal testing is best when you want to separate tumor-only changes from germline changes in one workflow. It is especially helpful if the first tumor report raised the possibility of an inherited PPGL syndrome but the germline status is still unclear.
What should relatives do if a germline variant is found?
If a pathogenic germline variant is confirmed, relatives may be offered targeted testing for the known family variant. That is usually more precise than broad panel testing for every relative and can shape surveillance sooner.